Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

86 results
Display

Eosinophilic Polymyositis and DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome by Antitubercular Agents

Shin KS, Park MS

Eosinophilic polymyositis (EPM) is a heterogeneous disorder characterized by eosinophilic infiltration into skeletal muscles. EPM is occasionally associated with a systemic disease, such as hypereosinophilic syndrome, connective tissue disease, or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful desensitization for antitubercular drugs

Lee AR, Kim SJ, Kim J, Park JH, Lee JK, Kim JY, Lee SY, Kang HR

Tuberculosis is an infectious disease that can be treated using a combination of antitubercular drugs. First-line antitubercular agents such as isoniazid and rifampin are considered pivotal to successful treatment. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of newly developed pulmonary lesion during the antitubercular agents in tuberculous pleurisy : A paradoxical response

Park JM, Shin YH, Chon GR, Shin HJ, Choi YC

Paradoxical response refers to the enlargement of old lesions or unexpected appearance of new lesions after initial improvement following treatment with antitubercular agents. Various types of paradoxical responses have been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
DRESS (drug reaction with eosinophilia and systemic symptom) syndrome caused by both first-line and second-line antitubercular medications: A case report with a brief literature review

Hwang YH, Jang DY, Kang SY, Sohn KH, Kang DY, Lee CH, Kang HR

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially fatal drug-induced systemic hypersensitivity response characterized by erythematous eruption, fever, leukocytosis with eosinophilia, and internal organ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Paradoxical Reaction after Treatment of Eyelid Tuberculosis

Seo Y, Choi M, Park CK, Yoon JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An opposing view on including high school students in a latent tuberculosis infection control program in Korea

Bae JM

The Korea Centers for Diseases Control and Prevention (KCDC) has announced a control program against latent Mycobacterium tuberculosis infection (LTBI), for a “TB-safe country” this year with the goal of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tuberculosis of the Breast

Kim SH, Jo KA, Kwon TH, Rho BS, Kim DS, Yoon KS

  • KMID: 1940074
  • J Korean Surg Soc.
  • 1997 Nov;53(5):631-634.
Tuberculosis of the breast is a rare disease. Its diagnosis is difficult because clinical and radiological appearances are not specific and because isolation of the tubercle bacillus from the lesion...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitamin D supplementation as a control program against latent tuberculosis infection in Korean high school students

Kim EH, Bae JM

The prevalence of latnet Mycobacterium tuberculosis infection (LTBI) in the first-grade high school students in South Korea was 2.1%, which was the lowest level at congregated settings in 2017. For...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tuberculosis Affecting Multiple Vertebral Bodies

Baba H, Tagami A, Adachi S, Hiura T, Osaki M

Spinal tuberculosis usually occurs in a single vertebral body or two to three adjacent vertebrae; it rarely occurs in multiple vertebral bodies. Surgery is indicated in cases that do not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapid desensitization to isoniazid and rifampin in an adolescent with active pulmonary tuberculosis

Lee H, Kim MS, Yang HK, Kim M, Lee JY, Kim JM, Kang JM, Kim YJ, Ahn K, Kim J

Hypersensitivity reactions to antituberculosis medicine are obstacles to the treatment of tuberculosis. However, rapid drug desensitization can secure successful treatment with essential antituberculosis medicines in pediatric patients. A 17-year-old boy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tuberculosis of the urachal cyst

Jindal T, Kamal MR, Jha JK

Urachal cysts are uncommon. Rarely, these cysts can become infected. Tuberculosis of the urachal cyst is exceedingly rare, with only one case reported previously in the English language literature. Here...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid

Choi JH, Heo NY, Park SH, Park CS, Jo KM, Kim WG, Nam KH

Anti-tuberculosis drugs can produce levels of hepatotoxicity ranging from mild elevation of aminotransferase to severe acute hepatitis. A few cases of drug-induced autoimmune hepatitis or the drug reaction with eosinophilia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of Multidrug Resistance during Standardized Treatment in a Patient with Drug-Sensitive Tuberculosis

Jeong YJ, Kang HJ, Choi SM, Han SK, Yim JJ

  • KMID: 2263562
  • Korean J Med.
  • 2012 May;82(5):614-617.
Standard short-course chemotherapy (SSC) is recommended for new patients with pulmonary tuberculosis (TB). This approach has been regarded as among the most effective tools for preventing the development of resistance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy

Eom JH, Yoon JH, Lee SW, Kim HS, Park TY, Bang CS, Baik GH, Kim DJ

Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is a common treatment modality for bladder cancer after transurethral resection of a bladder tumor. This therapy is generally safe, and development of a prostatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis

Kwon YS

The emergence of drug-resistant tuberculosis (TB) is a growing problem worldwide. The lack of safe and effective drugs, together with the frequent development of adverse drug reactions can result in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Drug Susceptible Pulmonary Tuberculosis

Shin HJ, Kwon YS

Tuberculosis (TB) remains a major global health problem, and the incidence of TB cases has not significantly decreased over the past decade in Korea. The standard short course regimen is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection

Lee NR, Jang JW, Kim HS, Yhim HY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

Yew WW, Koh WJ

A worsening scenario of drug-resistant tuberculosis has increased the need for new treatment strategies to tackle this worldwide emergency. There is a pressing need to simplify and shorten the current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Paradoxical Response Developed during the Antituberculous Treatment in Tuberculous Pleurisy

Song EJ, Baek DH, Jung JY, Lee SR, Lee MH, Lee SH, Lee JH, Lee KD, Lee BH, Kim SH

  • KMID: 2319037
  • Tuberc Respir Dis.
  • 2008 Jun;64(6):427-432.
BACKGROUND: A paradoxical response is defined as the radiological and clinical worsening of a previous lesion or the development of new lesion after initial improvement during theprocess of antituberculous treatment....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mycobacterium Szulgai Pulmonary Infection: Case Report of an Uncommon Pathogen in Korea

Kim JJ, Lee J, Jeong SY

Mycobacterium szulgai (M. szulgai) is an unusual pathogen in a human non-tuberculous mycobacterial infection. Pulmonary infection due to M. szulgai may be clinically and radiologically confused with active pulmonary tuberculosis....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr